Related Experiment Video
Updated: Jun 5, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Integrated transcriptomic analysis reveals lymphatic Icam1-mediated immune dynamics after myocardial infarction
Xue-Ting Chen1,2, Bei-Bei Hu3, Zhao Zhang1,2
1College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Intercellular adhesion molecule-1 (ICAM-1) in lymphatic endothelial cells (LECs) is crucial for resolving cardiac inflammation after myocardial infarction (MI). Its absence worsens injury by impairing immune cell clearance and promoting fibrosis.
Area of Science:
- Cardiovascular Biology
- Immunology
- Vascular Biology
Background:
- Cardiac lymphatic vessels regulate immune responses and inflammation resolution post-myocardial injury.
- Intercellular adhesion molecule-1 (ICAM-1) is key in leukocyte trafficking during inflammation.
- The role of ICAM-1 in lymphatic endothelial cells (LECs) post-myocardial infarction (MI) is not well understood.
Purpose of the Study:
- To investigate the function of ICAM-1 in LECs in the context of post-MI cardiac remodeling.
- To elucidate the impact of LEC-specific ICAM-1 deficiency on the cardiac immune microenvironment after MI.
Main Methods:
- Generated an LEC-specific ICAM-1 conditional knockout (cko) mouse model.
- Utilized single-cell RNA sequencing and spatial transcriptomics to analyze cardiac tissue at multiple time points post-MI.
- Performed cell-cell communication analysis to understand immune cell interactions.
Main Results:
- LEC-specific ICAM-1 deletion exacerbated post-MI inflammation and fibrotic remodeling, indicating aggravated cardiac injury.
- Transcriptomic analyses revealed significant alterations in cell composition, with expanded proinflammatory neutrophil and macrophage subsets.
- Deletion of ICAM-1 in LECs disrupted immune cell trafficking via lymphatic vessels, impairing inflammatory cell clearance and amplifying immune imbalance.
Conclusions:
- LEC ICAM-1 plays a critical role in regulating the immune microenvironment and tissue repair after myocardial infarction.
- Targeting LEC ICAM-1 presents a potential therapeutic strategy for improving outcomes following MI.
More Related Videos
06:38Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy
Published on: September 26, 2025
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
Published on: September 20, 2024